These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12955402)

  • 21. Pulmonary arterial hypertension secondary to chronic left-sided cardiac dysfunction in dogs.
    Stepien RL
    J Small Anim Pract; 2009 Sep; 50 Suppl 1():34-43. PubMed ID: 19765218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats.
    He H; Yang X; Shi M; Zeng X; Yang J; Wu L; Li L
    J Pharm Pharmacol; 2008 Jan; 60(1):115-23. PubMed ID: 18088512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impedance to gas transfer across the alveolar-capillary membrane in chronic cardiac failure.
    Guazzi M
    Ital Heart J; 2000 Mar; 1(3):169-73. PubMed ID: 10806983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential change in expression of pulmonary ET-1 and eNOS in rats after chronic left ventricular pressure overload.
    Tan MS; Chai CY; Wu JR; Yeh JL; Chen IJ; Kwan AL; Jeng AY; Yang HY; Lee MH; Dai ZK
    Exp Biol Med (Maywood); 2006 Jun; 231(6):948-53. PubMed ID: 16741029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure.
    Guazzi M; Tumminello G; Di Marco F; Guazzi MD
    Clin Pharmacol Ther; 2004 Oct; 76(4):371-8. PubMed ID: 15470337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arteriosclerotic changes in the myocardium, lung, and kidney in dogs with chronic congestive heart failure and myxomatous mitral valve disease.
    Falk T; Jönsson L; Olsen LH; Pedersen HD
    Cardiovasc Pathol; 2006; 15(4):185-93. PubMed ID: 16844549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wide-spread myocardial remodeling after acute myocardial infarction in rat. Features for heart failure progression.
    Krzemiński TF; Nozyński JK; Grzyb J; Porc M
    Vascul Pharmacol; 2008; 48(2-3):100-8. PubMed ID: 18276196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opposite effects of training in rats with stable and progressive pulmonary hypertension.
    Handoko ML; de Man FS; Happé CM; Schalij I; Musters RJ; Westerhof N; Postmus PE; Paulus WJ; van der Laarse WJ; Vonk-Noordegraaf A
    Circulation; 2009 Jul; 120(1):42-9. PubMed ID: 19546388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model of chronic heart failure in spontaneous hypertensive rats (SHR).
    Itter G; Jung W; Juretschke P; Schoelkens BA; Linz W
    Lab Anim; 2004 Apr; 38(2):138-48. PubMed ID: 15070453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
    Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pre- and postoperative assessment of hemodynamics in patients with chronic thromboembolic pulmonary hypertension by MR techniques].
    Ley S; Kramm T; Kauczor HU; Mayer E; Heussel CP; Thelen M; Kreitner KF
    Rofo; 2003 Dec; 175(12):1647-54. PubMed ID: 14661135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sildenafil on pulmonary hypertension and levels of ET-1, eNOS, and cGMP in aorta-banded rats.
    Dai ZK; Tan MS; Chai CY; Chou SH; Lin PC; Yeh JL; Jeng AY; Chang CI; Chen IJ; Wu JR
    Exp Biol Med (Maywood); 2006 Jun; 231(6):942-7. PubMed ID: 16741028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of chronic heart failure by overexpressing sarcoplasmic reticulum calcium ATPase through gene therapy: an experiment with rats].
    Li XY; Hui HP; Lu XC; Guo YT
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1174-8. PubMed ID: 16796857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of postobstructive vasculopathy after revascularization of chronically obstructed pulmonary artery.
    Fadel E; Michel RP; Eddahibi S; Bernatchez R; Mazmanian GM; Baudet B; Dartevelle P; Herve P
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1009-17. PubMed ID: 15052197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Greenberg B; Czerska B; Delgado RM; Bourge R; Zile MR; Silver M; Klapholz M; Haeusslein E; Mehra MR; Mather P; Abraham WT; Neaton JD; Brown BS; Parker IC; Konstam MA;
    Circulation; 2008 Sep; 118(12):1241-9. PubMed ID: 18765394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.